PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1424979
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1424979
Cell Freezing Media Market size was valued at USD 153.40 Million in 2022, expanding at a CAGR of 9.5% from 2023 to 2030.
Glycerol or dimethyl sulfoxide (DMSO) are examples of cryoprotective agents that should be present in freezing media. By lowering culture-medium freezing points and enabling slower cooling rates, these chemicals significantly minimize the possibility of ice crystal formation, which can harm or even kill untreated cells.
Cell Freezing Media Market- Market Dynamics
Increasing n-house freezing preparations and cryo preservative media to propel market demand
The advantages of the ready-to-use cryo-preservative media over traditional freezing techniques and the growing use of cell freezing media as a substitute for in-house freezing preparations are responsible for the market's growth. A wide spectrum of end users' growing need for efficient freezing media as well as the introduction of numerous new products by major industry players are also expected to drive market expansion. The creation of vaccines required cryopreservation because it was necessary for several processing steps, including transportation between facilities. Preparing ready-to-use freezing medium was made possible by the necessity for research institutes and biopharmaceutical manufacturers to embrace speedier turnaround times with effective solutions from their activities.
Furthermore, the research and development industry has seen a rise in partnerships, collaborations, and expansion investments, all of which contribute to the market's growth. For example, in order to promote cell line development and enhance the company's cell culture media portfolio, Sartorius invested about USD 31.6 million (EUR 30 million) and opened a new 65,000-square-foot Cell Culture Technology Centre in Ulm, Germany, in November 2021. The widespread acceptance of these media by end users has been made possible by their adaptability, affordability, and ease of use when compared to conventional freezing procedures.
Cell Freezing Media Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2023-2030)
Based on Product segmentation, DMSO (dimethyl sulfoxide) segment was predicted to show maximum market share in the year 2022, due to its wide adoption as a cryoprotectant.
Based on Application segmentation, stem cell lines segment was the leading segment in 2022, due to high demand from gene therapy and cell treatment.
Based on End-User segmentation, pharmaceutical & biotech segment was the leading segment in 2022, mainly due to growing demand for cell preservation.
On the basis of region, North America was the leading revenue generator in 2022, owing to advanced healthcare infrastructure.
The Global Cell Freezing Media Market is segmented on the basis of Product, Application, End-User, and Region.
The market is divided into three categories based on Product: DMSO, glycerol, and others. The DMSO segment dominates the market. The growing demand from oil & gas & chemical industries are expected to boost segment demand.
The market is divided into three categories based on Application: stem cell lines, cancer cell lines, and others. The stem cell lines segment dominates the market and is likely to maintain its dominance during the forecast period. The growing demand from biopharmaceuticals for gene therapies is boosting market growth.
The market is divided into three categories based on End-User: pharmaceutical & biotech, research institutes, and others. The pharmaceutical & biotech segment dominates the market and is likely to maintain its dominance during the forecast period. The cost effectiveness compared to traditional freezing technique has boosted the segment growth.
Cell Freezing Media Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The existence of sophisticated healthcare infrastructure, mature economies, major companies, and well-established supply chains all work together to propel the industry. Additionally, the biopharmaceutical sector is racing to produce cutting-edge and effective medications due to the expanding elderly population and the incidence of illnesses. The need for cell freezing media has been fueled by this, and it is anticipated that income generating will continue in the years to come.
To maintain their position in the market, the major companies in the cell freezing media are launching a number of strategic projects. Furthermore, many strategic efforts support market participants in expanding their commercial opportunities. The top companies in the market are focusing on technological advancements and innovation to bring down the price of products for efficient cell freezing solutions.
In March 2023, Nucleus Biologics, Center for breakthrough medicines, and Stoic Bio formed strategic collaboration to steady supply of quality-controlled cellular culture medium to enable cell and gene therapies development.